The case for the use of tranexamic acid

Paediatric Anaesthesia

Volumn 23, Issue 3, 2013, Pages 281-284

  Goobie, Susan ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR; TRANEXAMIC ACID;

BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); COLOR BLINDNESS; CORONARY ARTERY THROMBOSIS; DELIRIUM; DIARRHEA; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; GENETIC POLYMORPHISM; HEMOSTASIS; HUMAN; LOADING DRUG DOSE; NAUSEA; OCCLUSIVE CEREBROVASCULAR DISEASE; PEDIATRIC SURGERY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SEIZURE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; VISUAL IMPAIRMENT; VOMITING;

BLOOD LOSS, SURGICAL; CRANIOSYNOSTOSES; HUMANS;

EID: 84873471862     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/pan.12093     Document Type: Review

References (45)

1. Chadduck W,. Craniosynostosis. In:, Cheek W, ed. Pediatric Neurosurgery, 3rd edn. Houstan, TX: W.B. Saunders Company, 1994: 111-123.
2. Reiner D,. Intracranial pressure in craniosynostosis: pre- and postoperative recordings, correction with functional results. In:, Edgerton M, Jane S, eds. Scientific Foundation and Surgical Treatment of Craniosynostosis. Baltimore: Williams and Wilkins, 1989: 263-269.
3. White N, Marcus R, Dover S, et al,. Predictors of blood loss in fronto-orbital advancement and remodeling. J Craniofac Surg 2009; 20: 378-381.
4. Vamvakas EC,. Long-term survival rate of pediatric patients after blood transfusion. Transfusion 2008; 48: 2478-2480.
5. Czerwinski M, Hopper RA, Gruss J, et al,. Major morbidity and mortality rates in craniofacial surgery: an analysis of 8101 major procedures. Plast Reconstr Surg 2010; 126: 181-186.
6. Stricker PA, Shaw TL, Desouza DG, et al,. Blood loss, replacement, and associated morbidity in infants and children undergoing craniofacial surgery. Paediatr Anaesth 2010; 20: 150-159.
7. Phillips RJ, Mulliken JB,. Venous air embolism during a craniofacial procedure. Plast Reconstr Surg 1988; 82: 155-159.
8. Faberowski LW, Black S, Mickle JP,. Blood loss and transfusion practice in the perioperative management of craniosynostosis repair. J Neurosurg Anesthesiol 1999; 11: 167-172.
9. Ririe DG, Lantz PE, Glazier SS, et al,. Transfusion-related acute lung injury in an infant during craniofacial surgery. Anesth Analg 2005; 101: 1003-1006.
10. Tuncbilek G, Vargel I, Erdem A, et al,. Blood loss and transfusion rates during repair of craniofacial deformities. J Craniofac Surg 2005; 16: 59-62.
11. Williams GD, Ellenbogen RG, Gruss JS,. Abnormal coagulation during pediatric craniofacial surgery. Pediatr Neurosurg 2001; 35: 5-12.
12. Buntain SG, Pabari M,. Massive transfusion and hyperkalaemic cardiac arrest in craniofacial surgery in a child. Anaesth Intensive Care 1999; 27: 530-533.
13. Henry D, Carless P, Fergusson D, et al,. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ 2009; 180: 183-193.
14. Mangano DT, Miao Y, Vuylsteke A, et al,. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007; 297: 471-479.
15. Sethna NF, Zurakowski D, Brustowicz RM, et al,. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 2005; 102: 727-732.
16. Dunn CJ, Goa KL,. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999; 57: 1005-1032.
17. Eaton MP,. Antifibrinolytic therapy in surgery for congenital heart disease. Anesth Analg 2008; 106: 1087-1100.
18. Pharmacia and Upjohn Co DoP. Cyklokapron Drug Description. Package insert. New York, NY: Pharmacia and Upjohn Co DoP, 2008.
19. Reid R, Zimmerman A, Laussen P, et al,. The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg 1997; 84: 990-996.
20. Gruber E, Shukla A, Reid R, et al,. Synthetic antifibrinolytics are not associated with an increased incidence of baffle fenestration closure after the modified Fontan procedure. J Cardiothorac Vasc Anesth 2000; 15: 403-404.
21. Wong J, El Beheiry H, Rampersaud YR, et al,. Tranexamic Acid reduces perioperative blood loss in adult patients having spinal fusion surgery. Anesth Analg 2008; 107: 1479-1486.
22. Verma K, Errico TJ, Vaz KM, et al,. A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery. BMC Surg 2010; 10: 13.
23. Duran de la Fuente P, Garcia-Fernandez J, et al,. Usefulness of tranexamic acid in cranial remodeling surgery. Rev Esp Anestesiol Reanim 2003; 50: 388-394.
24. Goobie SM, Meier PM, Pereira LM, et al,. Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial. Anesthesiology 2011; 114: 862-871.
25. Dadure C, Sauter M, Bringuier S, et al,. Intraoperative tranexamic acid reduces blood transfusion in children undergoing craniosynostosis surgery: a randomized double-blind study. Anesthesiology 2011; 114: 856-861.
26. Goobie SM, Meier PM, Zurakowski D, et al,. The incidence of postoperative events as predictors for ICU admission in infants and children undergoing open craniosynostosis surgery. ASA Annu meet 2012: A805.
27. Stricker PA, Cladis FP, Fiadjoe JE, et al,. Perioperative management of children undergoing craniofacial reconstruction surgery: a practice survey. Paediatr Anaesth 2011; 21: 1026-1035.
28. Henry DA, Carless PA, Moxey AJ, et al,. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011, 3: CD001886.
29. Murkin JM, Falter F, Granton J, et al,. High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010; 110: 350-353.
30. Ngaage DL, Bland JM,. Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies. Eur J Cardiothorac Surg 2010; 37: 1375-1383.
31. Breuer T, Martin K, Wilhelm M, et al,. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery. Eur J Cardiothorac Surg 2009; 35: 167-171; author reply 171.
32. Martin K, Breuer T, Gertler R, et al,. Tranexamic acid versus varepsilon-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. Eur J Cardiothorac Surg 2011; 39: 892-897.
33. Schouten ES, van de Pol AC, Schouten AN, et al,. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis. Pediatr Crit Care Med 2009; 10: 182-190.
34. Livingston EH, Lee S,. Percentage of burned body surface area determination in obese and nonobese patients. J Surg Res 2000; 91: 106-110.
35. Abrishami A, Chung F, Wong J,. Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis. Can J Anaesth 2009; 56: 202-212.
36. Wong J, Abrishami A, El Beheiry H, et al,. Topical application of tranexamic Acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 2010; 92: 2503-2513.
37. Pellegrini A, Giaretta D, Chemello R, et al,. Feline generalized epilepsy induced by tranexamic acid (AMCA). Epilepsia 1982; 23: 35-45.
38. Murphy BA, Ririe DG, James RL, et al,. Simulated serum concentrations of tranexamic acid with clinically used dosing regimes in children during repair of congenital heart defects. Am Soc Anesthesiol 2001; 2001.
39. Dowd N, Karski J, Cheng D, et al,. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 2002; 97: 390-399.
40. Horrow JC, Van Riper DF, Strong MD, et al,. The dose-response relationship of tranexamic acid. Anesthesiology 1995; 82: 383-392.
41. Soslau G, Horrow J, Brodsky I,. Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am J Hematol 1991; 38: 113-119.
42. Goobie SM, Meier PM, Sethna NF, et al,. Population Pharmacokinetics of Tranexamic Acid in Pediatric Patients Undergoing Craniosynostosis Surgery. Clin Pharmacokinet 2013; in press.
43. Fiechtner BK, Nuttall GA, Johnson ME, et al,. Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesth Analg 2001; 92: 1131-1136.
44. Horrow J, Van Riper D, Strong M, et al,. The dose-response relationship of tranexamic acid. Anesthesiology 1995; 82: 383-392.
45. Iribarren JL, Jimenez JJ, Hernandez D, et al,. Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene. Anesthesiology 2008; 108: 596-602.